A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
To access this article, please choose from the options below
A list of the CARE-2 Investigators appears at the end of this article.
Trial registration: www.clinicaltrials.gov; study number: NCT00211939.
Originally published online as doi:10.1053/j.ajkd.2008.02.298 on April 17, 2008.
PII: S0272-6386(08)00526-X
doi:10.1053/j.ajkd.2008.02.298
© 2008 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
Refers to article:
- Calcification in CKD: No Closer to the Cure
